Arkolith/Insider Trading/IDYA/Form 4

Hata Yujiro S

President and CEO, DirectorIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Feb 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.5M
Net Open-Market Flow
-$4.5M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2024Option exercise(M)24K$4.31$102K701K
Feb 9, 2024Sell(S)24K$45.54$1.1M678K
Feb 8, 2024Option exercise(M)76K$4.31$327K754K
Feb 8, 2024Sell(S)76K$45.15$3.4M678K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2024Option exercise(M)24K—$0224K
Feb 8, 2024Option exercise(M)76K—$0248K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000053) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML